Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis and Rheumatism|April 18, 2012
Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritisSharon A Chung, Gang Xie, Delnaz Roshandel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisRodrigo Cartin-Ceba, Divya Indrakanti, Ulrich Specks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.
Annals of the Rheumatic Diseases|December 2, 2015
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA typeSebastian Unizony, Miguel Villarreal, Eli M Miloslavsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2016
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3Lynn A Fussner, Amber M Hummel, Darrell R Schroeder, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 22, 2014
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitisSebastian Unizony, Noha Lim, Deborah J Phippard, et al.
Arthritis Care & Research|September 29, 2011
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)Gunnar Tomasson, Maarten Boers, Michael Walsh, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
Plos One|January 27, 2012
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitisPaul A Monach, Philipp Kümpers, Alexander Lukasz, et al.
Pageof 18